top of page

Biobank and Sample Sharing​

As part of the Networking Activities of the TRANSVAC2 project, a database of the types of sample collections available at partner institutes has been established. These collections include different animal study derived products (sera, tissues etc.), mainly involving a biohazard level 3 or 4 for mice, NHP and non-rodent animals. These collections will continue to be developed during the project lifetime. Interested applicants are encouraged to contact directly TRANSVAC partner or transvacinvo@euvaccine.eu. ​

Overview of materials available through TRANSVAC2 The list is not exhaustive and its purpose is to initiate an individual discussion between a potential user and TRANSVAC partner (sample type, IP issues should be arranged case by case basis).

Sample Sharing - Overview.png

TRANSVAC2 and other biobank projects

There are several other biobank networks/projects – funded by the EU or other bodies – which TRANSVAC2 is aware of and will be listed in this section. TRANSVAC2 and its partners support these networks/projects, encourage researchers to use them and do not intend to offer materials which are already available through existing biobanks:

 

Regulatory Databases

Regulatory Support Databases

​

TRANSVAC2 Partner, ECRIN (European Clinical Trial Research Infrastructure Network) makes available a resource for information about clinical trial regulatory and ethical requirements covering 22 European countries and multiple study types such as clinical drug trials, clinical investigations of medical devices, combination drug-device studies and nutritional studies.

 

​

TRANSVAC2 Partner, EATRIS (European infrastructure for translational medicine) makes available a Regulatory Information system database. Potential users of the database shall contact EATRIS via link bellow.

​

Alternative Methods to Animal Models

​

TRANSVAC seeks to contribute to the 3Rs (Replacement, Reduction and Refinement) principle by providing the scientific community with Open Science tools and information to identify, develop and use 3R-based technologies to validate human and veterinary vaccines. Descriptions and information on non-animal methods are collected below.

 

 
 
bottom of page